Paloma Partners’s Aspen Aerogels ASPN Stock Holding History

Paloma Partners’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,175	Closed	-$284K	–	1880
2021 Q3	$284K	Buy	+6,175	New	+$245K	0.01%	739

Other funds holding ASPN

SCC

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Paloma Partners's ASPN Position: Q4 2021 in Review

Paloma Partners sold out of Aspen Aerogels (ASPN) in Q4 2021, closing a stake of 6,175 shares — an estimated $284K sold.

Paloma Partners first reported a position in ASPN in Q3 2021 and held it in 1 quarter. The position peaked at $284K in Q3 2021. 159 funds tracked by Wall St. Rank hold ASPN as of Q4 2021.

Paloma Partners reported no remaining Aspen Aerogels position as of Q4 2021 after selling out during the quarter.
Paloma Partners sold 6,175 Aspen Aerogels shares in Q4 2021, an estimated $284K.
Paloma Partners first reported a position in Aspen Aerogels in Q3 2021 and held it in 1 quarter.
Paloma Partners's Aspen Aerogels position peaked at $284K in Q3 2021.
159 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2021.

Based on Paloma Partners's 13F filing for Q4 2021, filed 14 Feb 2022.